Sort By

Primary Hyperoxaluria Type 1 Approved Drugs

These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Primary Hyperoxaluria Type 1.

Found 1 Approved Drug for Primary Hyperoxaluria Type 1

Oxlumo

Generic Name
Lumasiran
Form: Injection
Method of administration: Subcutaneous
FDA approval date: November 23, 2020
Summary: OXLUMO is indicated for the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels in pediatric and adult patients [see Clinical Pharmacology (1.
View Treatment
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances